Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A long term observational study in sickle cell disease will enhance the understanding of the disease patterns, current transfusion practices, treatments and outcomes in sickle cell disease.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| No treatment | Patients aged 2 to less than 12 | ||
| No treatment patients aged 12 to less than 18 | Patients aged 12 to less than 18 | ||
| No treatment Patients greater than 18 years | patients greater than 18 years |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Document current treatment patterns, natural history and outcomes in patients with sickle cell disease | up to 5 years |
| Measure | Description | Time Frame |
|---|---|---|
| Data collection | Collection of the following data:Current therapies used for the treatment of SCD Current transfusion practices, Difference in treatments between pediatric and adult patients, Use of chelation therapies, Frequency and types of crises including Frequency of hospitalizations, Incidence of end organ damage (caridac, renal, pulmonary,liver), Quality of life assessed by PedsQL TM Pediatric Quality of Life Inventory for patients 2- <18 years old and SF-36® Health Survey for patients 18 years old and older |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients with Sickle cell disease age 2 years and older
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Novartis Pharmaceuticals | Novartis Pharmaceuticals | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hematology Oncology Services of Arkansas | Little Rock | Arkansas | 72205 | United States | ||
| Children's Hospital Oakland (CHO) |
Not provided
Not provided
Not provided
Not provided
| up to 5 years |
| Measure Sickle cell crisis and hospitalizations | To evaluate whether patients on regular transfusion protocol have fewer crisis and hospitalizations | up to 5 years |
| Oakland |
| California |
| 94609 |
| United States |
| Children's Hospital of Orange County Sickle Cell Disease Center | Orange | California | 92668 | United States |
| Rady Children's Hopsital / UC San Diego University Hospital Sickle Cell Disease Center | San Diego | California | 92123 | United States |
| Hematology Oncology, P.C. | Stamford | Connecticut | 06902 | United States |
| Howard University | Washington D.C. | District of Columbia | 20060 | United States |
| Broward Oncology Associates, P.A. | Fort Lauderdale | Florida | 33308 | United States |
| Miami Children's Hospital | Miami | Florida | 33155 | United States |
| Innovative Medical Research | Miami | Florida | 33179 | United States |
| M.D. Anderson Cancer Center Orlando | Orlando | Florida | 32806 | United States |
| All Children's Hospital | St. Petersburg | Florida | 33701 | United States |
| Central Tampa Hematology and Oncology Associates | Tampa | Florida | 33607 | United States |
| St. Joseph Children's Hospital | Tampa | Florida | 33607 | United States |
| University of Illinois at Chicago, Dept of Pediatrics | Chicago | Illinois | 60612 | United States |
| Abington Hematology Oncology Associates, Inc | Oak Lawn | Illinois | 60453 | United States |
| Tulane University School of Medicine | New Orleans | Louisiana | 70112 | United States |
| LSU Department of Pediatrics Children's Hospital | New Orleans | Louisiana | 70118 | United States |
| Johns Hopkins University Division of Hematology | Baltimore | Maryland | 21205 | United States |
| Oncology-Hematology Associates, P.A. | Clinton | Maryland | 20735 | United States |
| Children's Hospital Boston - Harvard | Boston | Massachusetts | 02115 | United States |
| Boston Comprehensive Sickle Cell Center | Boston | Massachusetts | 02118 | United States |
| West Michigan Cancer Center | Kalamazoo | Michigan | 49007-3731 | United States |
| University of Missouri Child Health, Division of Pediatric Hematology/Oncology | Columbia | Missouri | 65212 | United States |
| Children's Mercy Hospital | Kansas City | Missouri | 64108 | United States |
| Research Medical Center | Kansas City | Missouri | 64132 | United States |
| Newark Beth Israel Medical Center | Newark | New Jersey | 07112 | United States |
| Maimonides Medical Center | Brooklyn | New York | 11209 | United States |
| New York Methodist Hospital Dept of Med/Sickle Cell Program | Brooklyn | New York | 11215 | United States |
| Interfaith Medical Center-Comprehensive Sickle Cell Program | Brooklyn | New York | 11238 | United States |
| Cohen Children's Medical Center of NY (CCMC) | New Hyde Park | New York | 11040 | United States |
| Center for Children's Cancer & Blood Disorders | Syracuse | New York | 13210 | United States |
| Presbyterian Hospital Pediatric Sickle Cell Program | Charlotte | North Carolina | 28204 | United States |
| Ohio Region VI Sickle Cell Program | Akron | Ohio | 44308 | United States |
| Cincinnati Children's Medical Center | Cincinnati | Ohio | 45229-3039 | United States |
| The Children's Medical Center of Dayton | Dayton | Ohio | 45404 | United States |
| Medical University of SC-Pediatric Sickle Cell Center | Charleston | South Carolina | 29425 | United States |
| M. Francisco Gonzalez, M.D., P.A. | Columbia | South Carolina | 29203 | United States |
| Diggs-Kraus Sickle Cell Center | Memphis | Tennessee | 38103 | United States |
| Meharry Comprehensive Sickle Cell Center | Nashville | Tennessee | 37208 | United States |
| Sickle Cell Disease and Hemoglobinopathy Clinic Children's Hospital at Vanderbilt | Nashville | Tennessee | 37232-6310 | United States |
| Baylor College of Medicine-Texas Children's Hospital | Houston | Texas | 77030-2399 | United States |
| Peninsula Cancer Institute | Newport News | Virginia | 23601 | United States |
| ID | Term |
|---|---|
| D000755 | Anemia, Sickle Cell |
| ID | Term |
|---|---|
| D000745 | Anemia, Hemolytic, Congenital |
| D000743 | Anemia, Hemolytic |
| D000740 | Anemia |
| D006402 | Hematologic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
| D006453 | Hemoglobinopathies |
| D030342 | Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Not provided
Not provided